It's earlybut far from being an overnight success. Their collaborative work with Uof A started in 2017 and in Sept. 2019 the report
had the following recommendation for further work;
Use of other polymers, polymer combinations, and cross-linked polymers can lead to improved delivery and release profiles of drugs/bioactives, which is our ongoing investigation. A year and a half later, it's all done now, 5 years in the making and culminating in the following by Gilles
, "With these important findings, we have established an expanded PGX-based product pipeline further supporting the investment decision for the commercial scale up of the PGX Technology for the processing of oat beta glucan, yeast beta glucan and alginate."